701 related articles for article (PubMed ID: 33918947)
1. Dual Roles of Microglia in the Basal Ganglia in Parkinson's Disease.
Choudhury ME; Kigami Y; Tanaka J
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918947
[TBL] [Abstract][Full Text] [Related]
2. Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus.
Aono H; Choudhury ME; Higaki H; Miyanishi K; Kigami Y; Fujita K; Akiyama JI; Takahashi H; Yano H; Kubo M; Nishikawa N; Nomoto M; Tanaka J
Glia; 2017 Nov; 65(11):1833-1847. PubMed ID: 28836295
[TBL] [Abstract][Full Text] [Related]
3. Functional changes of the basal ganglia circuitry in Parkinson's disease.
Blandini F; Nappi G; Tassorelli C; Martignoni E
Prog Neurobiol; 2000 Sep; 62(1):63-88. PubMed ID: 10821982
[TBL] [Abstract][Full Text] [Related]
4. Synaptic and cellular plasticity in Parkinson's disease.
Chu HY
Acta Pharmacol Sin; 2020 Apr; 41(4):447-452. PubMed ID: 32112041
[TBL] [Abstract][Full Text] [Related]
5. Anatomy of the dopamine system in the basal ganglia.
Smith Y; Kieval JZ
Trends Neurosci; 2000 Oct; 23(10 Suppl):S28-33. PubMed ID: 11052217
[TBL] [Abstract][Full Text] [Related]
6. Substantia nigra control of basal ganglia nuclei.
Guatteo E; Cucchiaroni ML; Mercuri NB
J Neural Transm Suppl; 2009; (73):91-101. PubMed ID: 20411770
[TBL] [Abstract][Full Text] [Related]
7. Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease.
Milosevic L; Kalia SK; Hodaie M; Lozano AM; Fasano A; Popovic MR; Hutchison WD
Brain; 2018 Jan; 141(1):177-190. PubMed ID: 29236966
[TBL] [Abstract][Full Text] [Related]
8. Role of HCN channels in the functions of basal ganglia and Parkinson's disease.
Qi ZX; Yan Q; Fan XJ; Peng JY; Zhu HX; Jiang YM; Chen L; Zhuang QX
Cell Mol Life Sci; 2024 Mar; 81(1):135. PubMed ID: 38478096
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
10. Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson's disease.
Milosevic L; Gramer R; Kim TH; Algarni M; Fasano A; Kalia SK; Hodaie M; Lozano AM; Popovic MR; Hutchison WD
Neurobiol Dis; 2019 Apr; 124():46-56. PubMed ID: 30391540
[TBL] [Abstract][Full Text] [Related]
11. MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease.
Kosta P; Argyropoulou MI; Markoula S; Konitsiotis S
J Neurol; 2006 Jan; 253(1):26-32. PubMed ID: 15981079
[TBL] [Abstract][Full Text] [Related]
12. Glutamate and Parkinson's disease.
Blandini F; Porter RH; Greenamyre JT
Mol Neurobiol; 1996 Feb; 12(1):73-94. PubMed ID: 8732541
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease.
Miguelez C; Morera-Herreras T; Torrecilla M; Ruiz-Ortega JA; Ugedo L
Front Neural Circuits; 2014; 8():21. PubMed ID: 24672433
[TBL] [Abstract][Full Text] [Related]
14. GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation.
Betarbet R; Porter RH; Greenamyre JT
J Neurochem; 2000 Mar; 74(3):1166-74. PubMed ID: 10693949
[TBL] [Abstract][Full Text] [Related]
15. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.
Teismann P; Schulz JB
Cell Tissue Res; 2004 Oct; 318(1):149-61. PubMed ID: 15338271
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of kainate receptors in the basal ganglia of the developing and adult rat brain.
Wüllner U; Standaert DG; Testa CM; Penney JB; Young AB
Brain Res; 1997 Sep; 768(1-2):215-23. PubMed ID: 9369318
[TBL] [Abstract][Full Text] [Related]
17. Extrastriatal dopaminergic circuits of the Basal Ganglia.
Rommelfanger KS; Wichmann T
Front Neuroanat; 2010; 4():139. PubMed ID: 21103009
[TBL] [Abstract][Full Text] [Related]
18. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion.
Porter RH; Greene JG; Higgins DS; Greenamyre JT
J Neurosci; 1994 Nov; 14(11 Pt 2):7192-9. PubMed ID: 7965108
[TBL] [Abstract][Full Text] [Related]
19. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
20. [Recent advances in research on basal ganglia. Introduction].
Takada M
Brain Nerve; 2009 Apr; 61(4):338-9. PubMed ID: 19378802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
